Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Rl, Haas"'
Autor:
Cp, Raut, Miceli R, Dc, Strauss, Cj, Swallow, Hohenberger P, van Coevorden F, Rutkowski P, Fiore M, Callegaro D, Pg, Casali, Rl, Haas, Aj, Hayes, Honore C, Aj, Cannell, Jakob J, Szacht M, Fairweather M, Re, Pollock, Bonvalot S, Alessandro Gronchi
Publikováno v:
Europe PubMed Central
Cancer, 122(9), 1417-1424
Cancer, 122(9), 1417-1424
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::afcef3acd2853385baf982d170c46d97
https://doi.org/10.1002/cncr.29931
https://doi.org/10.1002/cncr.29931
Autor:
Rl Haas
Publikováno v:
European Journal of Cancer. 33:1055-1060
Dermatofibrosarcoma protuberans (DFSP), a fibrohistiocytic tumour of intermediate malignancy, has a strong tendency to recur locally. Wide local excision is the recommended treatment modality. A retrospective analysis was performed on 38 consecutive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0506b936189dc36ad442d103fee745f0
https://doi.org/10.1016/s0959-8049(97)00026-9
https://doi.org/10.1016/s0959-8049(97)00026-9
Autor:
Baldini EH; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA., Guadagnolo BA; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX., Salerno KE; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD., Chung P; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada., Bishop AJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX., Kalbasi A; Department of Radiation Oncology and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Miah A; Department of Radiation Oncology, Royal Marsden Hospital, London, United Kingdom., Bedi M; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI., Harris JP; Department of Radiation Oncology, University of California, Irvine, Orange, CA., Petersen I; Department of Radiation Oncology, Mayo Clinic, Rochester, MN., Gillham C; St Luke's Radiation Oncology Network, Rathgar, Dublin, Ireland., Wiltink LM; Department of Radiotherapy, Leiden University Medical Center, Amsterdam, the Netherlands., Alektiar KM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY., Haas RL; Department of Radiotherapy, Leiden University Medical Center, Amsterdam, the Netherlands.; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kirsch DG; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 20; Vol. 42 (36), pp. 4240-4245. Date of Electronic Publication: 2024 Sep 04.
Autor:
Kruiswijk AA; Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; Orthopedic Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Electronic address: a.a.kruiswijk@lumc.nl., Engelhardt EG; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, the Netherlands., Vlug LAE; Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., van de Wal RJP; Orthopedic Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Schrage YM; Department of Surgical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., van de Sande MAJ; Orthopedic Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands., Marang-van de Mheen PJ; Safety & Security Science, Faculty of Technology, Policy & Management, Delft University of Technology, Jaffalaan 5, 2628 BX Delft, the Netherlands., van Bodegom-Vos L; Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Oct; Vol. 210, pp. 114269. Date of Electronic Publication: 2024 Aug 09.
Autor:
van der Laan P; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: p.vd.laan@nki.nl., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Broek D; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Boven H; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Heeres BC; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schrage Y; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.v.houdt@nki.nl.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Sep; Vol. 50 (9), pp. 108530. Date of Electronic Publication: 2024 Jul 04.
Autor:
Kasper B; Sarcoma Unit, Mannheim Cancer Center (MCC), Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Baldini EH; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Bonvalot S; Department of Surgery, Institut Curie, Comprehensive Cancer Center, Paris, France., Callegaro D; Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Cardona K; Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine and Winship Cancer Institute, Atlanta, Georgia., Colombo C; Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Corradini N; Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France., Crago AM; Department of Surgery, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Dei Tos AP; Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy., Dileo P; Department of Oncology, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdom., Elnekave E; Unit of Interventional Radiology, Shaare Tzedek Medical Center, Jerusalem, Israel., Erinjeri JP; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Navid F; Department of Pediatrics, Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California., Farma JM; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Ferrari A; Deparment of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fiore M; Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Gladdy RA; Division of Surgical Oncology, Department of Surgery, University of Toronto, Ontario, Canada.; Department of Surgery, Mount Sinai Hospital, Sinai Health Systems, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Gounder M; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Haas RL; Department of Radiotherapy, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands., Husson O; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kurtz JE; Department of Medical and Surgical Oncology & Hematology, Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston., Orbach D; SIREDO (Care, Innovation & Research in Childhood, Adolescent & Young-Adult Oncology) Oncology Center, Institut Curie, Paris Sciences et Lettres University, Paris, France., Penel N; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Raut CP; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Schut AW; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Sparber-Sauer M; Stuttgart Cancer Center, Zentrum für Kinder- und Jugend Frauenmedizin, Pädiatrie 5, Klinikum Stuttgart, Stuttgart, Germany., Strauss DC; Sarcoma and Melanoma Unit, Department of Academic Surgery, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Vitellaro M; Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Weiss AR; Division of Hematology-Oncology, Department of Pediatrics, Maine Medical Center, Portland., Gronchi A; Department of Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Aug 01; Vol. 10 (8), pp. 1121-1128.
Autor:
Holthuis EI; Medical Oncology Department, NKI-AVL-Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Heins MJ; Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands., van Houdt WJ; Surgical Oncology Department, NKI-AVL-Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Haas RL; Department of Radiotherapy, NKI-AVL-Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Overbeek JA; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Olde Hartman TC; Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute of Medical Innovation, Nijmegen, the Netherlands., Uijen AA; Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute of Medical Innovation, Nijmegen, the Netherlands., Wee L; School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, the Netherlands., van der Graaf WTA; Medical Oncology Department, NKI-AVL-Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Husson O; Medical Oncology Department, NKI-AVL-Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2024 Jun; Vol. 8, pp. e2400054.
Autor:
Roets E; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands., van der Graaf W; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Department of Medical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, Rotterdam 3015 GD, the Netherlands., van Riet BHG; Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, the Netherlands., Younger E; Sarcoma Unit, Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, United Kingdom., Sparano F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA) Data Center, Rome, Italy., Wilson R; Sarcoma Patients Advocacy Global Network, Untergasse 36, Wölfersheim D-61200, Germany; Sarcoma UK, 17/18 Angel Gate, City Road, London, UK., van der Mierden S; Scientific information service, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands., Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA) Data Center, Rome, Italy., Husson O; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Department of Surgical Oncology, ErasmusMC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, Rotterdam 3015 GD, the Netherlands. Electronic address: o.husson@nki.nl.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 May; Vol. 197, pp. 104345. Date of Electronic Publication: 2024 Apr 04.
Autor:
Callegaro D; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Barretta F; Department of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Raut CP; Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Johnston W; Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada., Strauss DC; Sarcoma Unit, Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, United Kingdom., Honoré C; Department of Surgery, Institut Gustave Roussy, Villejuif, France., Bonvalot S; Department of Surgery, Institut Curie, Paris, France., Fairweather M; Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gladdy RA; Department of Surgical Oncology, Princess Margaret Cancer Centre, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Surgery, University of Toronto, Toronto, ON, Canada., Tirotta F; Sarcoma Unit, Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Tzanis D; Department of Surgery, Institut Curie, Paris, France., Skoczylas J; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Haas RL; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Miceli R; Department of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Swallow CJ; Department of Surgical Oncology, Princess Margaret Cancer Centre, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Surgery, University of Toronto, Toronto, ON, Canada., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Annals of surgery [Ann Surg] 2024 May 01; Vol. 279 (5), pp. 857-865. Date of Electronic Publication: 2023 Sep 27.
Autor:
Embaby A; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands. Electronic address: a.embaby@nki.nl., Heinhuis KM; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., IJzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Koenen AM; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., van der Kleij S; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Hofland I; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., van Boven H; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Pharmacology, Princess Màxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113974. Date of Electronic Publication: 2024 Mar 02.